Type: Product
Name: Intelence
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

Can Gilead Dominate The HIV Drug Market Again in 2014?

Sales from Gilead's HIV drugs totaled more than $9 billion last year, providing Gilead with the cash necessary to usher its new hepatitis C drug, Sovaldi, to market, and advance its $ idelalisib, through trials. $ As a result, Gilead's shares doubled ... [Published Motley Fool - Mar 12 2014]
First reported Dec 10 2013 - Updated Dec 10 2013 - 1 reports

Janssen launches first-of-its-kind paediatric HIV treatment donation programme in sub-Saharan Africa

Janssen, the pharmaceutical companies of Johnson & Johnson, has launched a first-of-its-kind paediatric HIV treatment donation programme to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan ... [Published PharmaBiz - Dec 10 2013]


...and are in need of new treatment options," said Paul Stoffels, MD, chief scientific officer, Johnson & Johnson and worldwide chairman, Janssen. "We hope this innovative donation programme is the first step in sparking further collaborative action across sub-Saharan Africa for children who are experiencing HIV treatment failure. Our vision is that these children receive the HIV treatment and care they need to stay healthy and grow to become healthy, productive young adults."

More Content

All (2) | News (2) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Can Gilead Dominate The HIV Drug Market Again i... [Published Motley Fool - Mar 12 2014]
Janssen launches first-of-its-kind paediatric H... [Published PharmaBiz - Dec 10 2013]
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.